Pro Numb Tattoo Numbing Spray Recalled Nationwide Due to Manufacturing Deviations
Pro Numb Tattoo Numbing Spray LLC has voluntarily recalled its Pro Numb Sensitive Skin spray (Lot J15) due to Current Good Manufacturing Practice (cGMP) deviations.
What Happened
Pro Numb Tattoo Numbing Spray LLC has initiated a voluntary recall of its Pro Numb Sensitive Skin numbing spray. The U.S. Food and Drug Administration (FDA) has designated this as a Class II recall following the discovery of Current Good Manufacturing Practice (cGMP) deviations. The recall was officially initiated on February 2, 2026.
Which Products Are Affected
The recall involves specific lots of the following topical drug product distributed nationwide across the United States:
- Product Name: Pro Numb Tattoo Numbing Spray, For Sensitive Skin (4% Lidocaine)
- Sizes: 1 FL OZ (28.4 mL) or 4 oz (120 mL) bottles
- NDC Number: 83389-112-11
- Lot Number: J15
- Recall Number: D-0303-2026
- Manufacturer: Pro Numb Tattoo Numbing Spray LLC, based in Palm Bay/Melbourne, FL.
What You Should Do
Consumers who have purchased the affected Pro Numb Tattoo Numbing Spray from Lot J15 should stop using the product immediately. The manufacturer initiated the recall process via notification letters. Consumers seeking information regarding returns or refunds should contact Pro Numb Tattoo Numbing Spray LLC directly at their Palm Bay, Florida, location.
Why This Matters
Adherence to Current Good Manufacturing Practices (cGMP) is essential to ensure that over-the-counter drug products meet the necessary standards for safety, quality, and purity. Deviations from these practices can compromise the integrity of the medication.
Source
This report is based on official recall documentation provided by the U.S. Food and Drug Administration (FDA).
Source: FDA Official Notice
Related Articles
Philips Recalls Azurion 7 M20 Systems Due to Unexpected Table Movement
FDA · February 24, 2026
Medline Industries Recalls 14 Fr Suction Catheter Kits Due to Incorrect Component Sizing
FDA · February 24, 2026
Philips Recalls Azurion 7 M12 Systems Due to Unexpected Table Movement Hazard
FDA · February 24, 2026